Sabinsa was recognized in a certificate of appreciation by the United States Pharmacopoeia (USP) for providing candidate documentary and reference standards that helped USP reach milestones in 2023, as well as contributions toward global public health through advancing standards.
The Sami-Sabinsa Group has been working with USP for more than 20 years on projects related to reference standards, and has been a consistent source for USP of reference standards for the herbal industry, including all three active curcuminoids.
Reference standards are used to assess identity, potency, quality, and purity of dietary supplement and active pharmaceutical ingredients. They are the most critical requirement of any quantitative or qualitative analysis, and are necessary to provide a standardized product.
“The Sami-Sabinsa Group manufactures and promotes standardized products with innovative molecules worldwide and understands the requirements when it comes to testing such molecules,” said Asha Ramesh, CEO of Sabinsa US. “We stepped up in providing unmatched quality reference standards to USP, a worldwide accepted, independent scientific nonprofit organization which is focused on building trust in the supply of safe, high-quality ingredients for dietary supplements.”
